temozolomide has been researched along with gossypol acetic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Adamski, V; Adelung, R; Ceynowa, F; Hattermann, K; Held-Feindt, J; Lucius, R; Schmitt, C; Synowitz, M | 1 |
Adamski, V; Adelung, R; Hattermann, K; Held-Feindt, J; Lucius, R; Rasch, F; Schmitt, C; Synowitz, M | 1 |
Caylioglu, D; Held-Feindt, J; Hellmold, D; Kubelt, C; Meyer, RJ; Synowitz, M | 1 |
Adelung, R; Beckinger, S; Daunke, T; Haag, J; Hauck, M; Held-Feindt, J; Hellmold, D; Janssen, O; Kubelt, C; Lucius, R; Schütt, F; Sebens, S; Synowitz, M | 1 |
4 other study(ies) available for temozolomide and gossypol acetic acid
Article | Year |
---|---|
Effects of sequentially applied single and combined temozolomide, hydroxychloroquine and AT101 treatment in a long-term stimulation glioblastoma in vitro model.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Growth Processes; Cell Line, Tumor; Dacarbazine; Drug Administration Schedule; Drug Synergism; Glioblastoma; Gossypol; Humans; Hydroxychloroquine; Temozolomide | 2018 |
Establishment of a glioblastoma in vitro (in)complete resection dual co-culture model suitable for drug testing.
Topics: Analysis of Variance; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Astrocytes; Brain; Coculture Techniques; Glioblastoma; Gossypol; Humans; Microglia; Temozolomide | 2020 |
Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Glioblastoma; Glioma; Gossypol; Humans; Neoplastic Stem Cells; Signal Transduction; Stem Cell Niche; Temozolomide; Tumor Microenvironment | 2021 |
Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Gossypol; Humans; Neoplasm Recurrence, Local; Temozolomide; TOR Serine-Threonine Kinases | 2023 |